Opportunity
Massachusetts COMMBUYS #BD-27-1031-BSAS0-BSA01-131809
Programmatic Support for First Responders - TTA Opioid Overdose Prevention
Posted
July 29, 2026
Respond By
August 07, 2026
Identifier
BD-27-1031-BSAS0-BSA01-131809
NAICS
624190, 621420, 813319
This opportunity is issued by the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (BSAS), focusing on support for the First Responders - TTA program application: - Government Buyer: - Massachusetts Department of Public Health, Bureau of Substance Addiction Services (BSAS) - Program Objective: - Reduce opioid overdose deaths through evidence-based prevention and response initiatives - Expand access to medications for opioid use disorder (MOUD) - Strengthen first responder capacity - Improve linkages to treatment and recovery services - Partnerships Required: - Collaboration among first responders, healthcare providers, public health agencies, peer recovery organizations, and community-based organizations - Products/Services Requested: - Development assistance and programmatic support for opioid overdose prevention and response - No specific products, part numbers, or OEMs are identified - Unique/Notable Requirements: - Emphasis on cross-sector partnerships and programmatic expertise in opioid overdose prevention - Focus on evidence-based strategies and expanding access to MOUD - No OEMs or specific vendors are named in this notice
Description
The Massachusetts Department of Public Health, Bureau of Substance Addiction Services, intends to apply for the SAMHSA FY 2026 First Responders - TTA program. The program aims to reduce opioid overdose deaths by expanding evidence-based overdose prevention, increasing access to medications for opioid use disorder, strengthening first responder capacity, and improving linkages to treatment and recovery. It emphasizes partnerships among first responders, healthcare providers, public health agencies, peer recovery organizations, and community-based organizations to ensure timely engagement and ongoing support for individuals who experience an overdose.